Kooij Louise Frederika 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Kooij Louise Frederika（CIK 2004379）在 1 家公司共报告 37 笔 SEC Form 4 内部人交易（最近一笔 2026-07-22）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-22 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 25,000 | $297,500 |
| 2026-07-22 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 80,000 | $893,600 |
| 2026-07-22 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 70,200 | $2.1M |
| 2026-07-22 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 31,885 | $990,029 |
| 2026-07-22 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 2,915 | $92,435 |
| 2026-06-24 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 25,000 | $272,500 |
| 2026-06-24 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 15,000 | $178,500 |
| 2026-06-24 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 39,700 | $1.2M |
| 2026-06-24 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 300 | $9,219 |
| 2026-05-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 60,000 | $600,000 |
| 2026-05-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 5,000 | $54,500 |
| 2026-05-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 65,000 | $2.3M |
| 2026-01-29 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 39,816 | $433,994 |
| 2026-01-29 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 39,816 | $1.3M |
| 2026-01-29 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 32,612 | $355,471 |
| 2026-01-29 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 32,612 | $1.0M |
| 2026-01-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 38,172 | $416,075 |
| 2026-01-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 25,405 | $849,543 |
| 2026-01-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 12,767 | $438,802 |
| 2026-01-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 34,400 | $374,960 |
| 2026-01-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 34,091 | $1.1M |
| 2026-01-27 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 309 | $10,336 |
| 2026-01-07 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 卖出 | 2,647 | $88,013 |
| 2026-01-07 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 12,000 | $0 |
| 2025-12-29 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | 买入 | 75,117 | $751,170 |
来源：SEC Form 4 申报文件 · 截至 2026-07-22